Autologous bone marrow mesenchymal stromal cell therapy for “no-option” critical limb ischemia is limited by karyotype abnormalities

Overview of attention for article published in Cytotherapy, April 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 10 X users

Readers on

mendeley: 62 Mendeley

Summary X

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 35,044 followers.

We may need to be careful with autologous stem cell therapy in #inflammation associated diseases because according to this paper they may have karyotypic abnormalities. https://t.co/8ovfXGf7Fr

07 Aug 2023

Reply Repost Favourite

RT @Reg_Med_NUIG: https://t.co/dlseRBA61n… Publication on the first ex vivo expanded cell therapy Clinical Trial in Ireland. Conducted at G…

18 May 2020

Reply Repost Favourite

RT @Reg_Med_NUIG: https://t.co/dlseRBA61n… Publication on the first ex vivo expanded cell therapy Clinical Trial in Ireland. Conducted at G…

18 May 2020

Reply Repost Favourite

RT @Reg_Med_NUIG: https://t.co/dlseRBA61n… Publication on the first ex vivo expanded cell therapy Clinical Trial in Ireland. Conducted at G…

14 May 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.